Case Study: Accelerated Phase I Bioanalytical Support for a CNS Small Molecule Under FDA Fast Track
Navigating Clinical Translation of CNS Small Molecules Under FDA Fast Track The clinical translation of central nervous system (CNS)-active small […]
What Happens If a Bioanalytical Method Fails Validation? Next Steps and Recovery Strategies
Introduction: A bioanalytical method validation failure is one of the most operationally significant and regulatorily sensitive events in drug development.
Disulfide Bond Mapping in Therapeutic Peptides: LC-MS Strategies and Analytical Challenges
Introduction: Disulfide Bond Mapping in Therapeutic Peptides is a critical analytical process used to verify the structural integrity and biological
Tissue and CSF Bioanalytical Services for CNS Drug Development Programs
Introduction: Why Tissue and CSF Bioanalysis Is the Defining Step in CNS Drug Development One of the greatest challenges in
Tissue and CSF Bioanalytical Services for CNS Drug Development Programs Read More »
Case Study: Dual Analyte LC-MS/MS Bioanalysis for an Antibody-Drug Conjugate Program
Introduction: The Bioanalytical Complexity of ADC Programs Bioanalysis for an Antibody-Drug Conjugate Program is far from a straightforward analytical exercise.
Case Study: Dual Analyte LC-MS/MS Bioanalysis for an Antibody-Drug Conjugate Program Read More »
Regulated Bioanalytical Services for NDA and BLA Submissions: What to Look for in a CRO
Introduction: Why CRO Selection Is a Regulatory Decision, Not Just a Scientific One When sponsors prepare regulated bioanalytical services for
Regulated Bioanalytical Services for NDA and BLA Submissions: What to Look for in a CRO Read More »
GLP-1 Biosimilars: Mass Spectrometry Challenges in Semaglutide and Exenatide Characterization
Introduction: The rapid expansion of GLP-1 receptor agonist therapeutics has increased the need for robust GLP-1 Biosimilar Characterization strategies. Peptide
Bioanalytical CRO Services for Phase II and Phase III Clinical Trials
Introduction: Why Late-Phase Bioanalysis Requires a Different Approach As a clinical development program progresses into Phase II and Phase III,
Bioanalytical CRO Services for Phase II and Phase III Clinical Trials Read More »
What Is Incurred Sample Reanalysis (ISR) and Why Does It Matter in Bioanalytical Studies?
Introduction: The Real Test of a Bioanalytical Method Begins After Validation Method validation confirms that a bioanalytical method performs reliably
EMA vs FDA Bioanalytical Method Validation: Key Regulatory Differences Explained
Introduction: Why EMA vs FDA Bioanalytical Method Validation Differences Matter Understanding EMA vs FDA Bioanalytical Method Validation Differences is extremely
EMA vs FDA Bioanalytical Method Validation: Key Regulatory Differences Explained Read More »